ONT vs. BTG, ABC, GNS, ERGO, SLN, PRTC, OXB, HZD, VRP, and FARN
Should you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include BTG (BTG), Abcam (ABC), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), and Faron Pharmaceuticals Oy (FARN). These companies are all part of the "biotechnology" industry.
Oxford Nanopore Technologies vs.
BTG (LON:BTG) and Oxford Nanopore Technologies (LON:ONT) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, community ranking, dividends and earnings.
BTG has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks.
In the previous week, BTG had 3 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 3 mentions for BTG and 0 mentions for Oxford Nanopore Technologies. BTG's average media sentiment score of 0.17 beat Oxford Nanopore Technologies' score of 0.00 indicating that BTG is being referred to more favorably in the media.
BTG received 586 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 73.95% of users gave BTG an outperform vote.
Oxford Nanopore Technologies has a consensus price target of GBX 235.50, suggesting a potential upside of 101.63%. Given Oxford Nanopore Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Oxford Nanopore Technologies is more favorable than BTG.
38.4% of Oxford Nanopore Technologies shares are owned by institutional investors. 32.6% of Oxford Nanopore Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
BTG has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. BTG's return on equity of 0.00% beat Oxford Nanopore Technologies' return on equity.
Summary
BTG beats Oxford Nanopore Technologies on 9 of the 15 factors compared between the two stocks.
Get Oxford Nanopore Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for ONT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford Nanopore Technologies Competitors List
Related Companies and Tools
This page (LON:ONT) was last updated on 2/22/2025 by MarketBeat.com Staff
Free ONT Stock Alerts